There is a listed non-life insurer in which Fairfax holds a non-majority but still significant stake. It trades at 7× P/E, has an ROE in the high teens, and has consistently maintained a combined ratio in the low to mid-90s. It operates in a market where GDP growth is averaging 8%, and where consumers are just hitting the S-curve, as indicated by GDP per capita. The float is limited, so it is not easy to accumulate shares. However, for those with patience, it presents a compelling opportunity. They had a small banner at one of the booths at the recent Fairfax AGM, but I doubt many people here have even heard of it.